Martine Rothblatt Insider Trading Activity
Martine Rothblatt has been net-selling over the last 12 months with 1 purchase and 967 sales across 1 company.
UTHR is the most-traded position with 968 trades. The largest single transaction was a sale of UTHR for $2.5M on May 22, 2026.
Performance Scorecard
Forward stock performance after each transaction by Martine Rothblatt. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | -5.7% | -2.8% | 46% | 903 |
| 90 days | — | -2.8% | 36% | 660 |
| 120 days | — | -9.4% | 12% | 413 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersUTHR · UNITED THERAPEUTICS Corp
🔒 Subscribe to see trade entries
Pro members see exactly when Martine Rothblatt bought and sold UTHR.
Upgrade to ProRecent Trades
Showing the 50 most recent of 968 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 21, 2026 | UTHR | Sell | 2,605 | $531.52 | $1.4M | −0.8% | CEO | |
Jul 21, 2026 | UTHR | Sell | 640 | $533.58 | $341K | −0.2% | CEO | |
Jul 21, 2026 | UTHR | Sell | 160 | $526.24 | $84K | −0.0% | CEO | |
Jul 21, 2026 | UTHR | Sell | 509 | $529.55 | $270K | −0.2% | CEO | |
Jul 21, 2026 | UTHR | Sell | 120 | $524.37 | $63K | −0.0% | CEO | |
Jul 21, 2026 | UTHR | Sell | 341 | $535.44 | $183K | −0.1% | CEO | |
Jul 21, 2026 | UTHR | Sell | 360 | $532.47 | $192K | −0.1% | CEO | |
Jul 21, 2026 | UTHR | Sell | 1,760 | $534.61 | $941K | −0.5% | CEO | |
Jul 21, 2026 | UTHR | Sell | 240 | $527.46 | $127K | −0.1% | CEO | |
Jul 21, 2026 | UTHR | Sell | 839 | $536.37 | $450K | −0.3% | CEO | |
Jul 21, 2026 | UTHR | Sell | 1,926 | $530.50 | $1.0M | −0.6% | CEO | |
Jul 17, 2026 | UTHR | Sell | 892 | $542.06 | $484K | −0.3% | CEO | |
Jul 17, 2026 | UTHR | Sell | 2,110 | $536.36 | $1.1M | −0.6% | CEO | |
Jul 17, 2026 | UTHR | Sell | 1,160 | $537.45 | $623K | −0.4% | CEO | |
Jul 17, 2026 | UTHR | Sell | 293 | $542.43 | $159K | −0.1% | CEO | |
Jul 17, 2026 | UTHR | Sell | 2,350 | $535.53 | $1.3M | −0.7% | CEO | |
Jul 17, 2026 | UTHR | Sell | 720 | $534.57 | $385K | −0.2% | CEO | |
Jul 17, 2026 | UTHR | Sell | 240 | $528.91 | $127K | −0.1% | CEO | |
Jul 17, 2026 | UTHR | Sell | 251 | $540.69 | $136K | −0.1% | CEO | |
Jul 17, 2026 | UTHR | Sell | 423 | $538.70 | $228K | −0.1% | CEO | |
Jul 17, 2026 | UTHR | Sell | 821 | $539.63 | $443K | −0.3% | CEO | |
Jul 15, 2026 | UTHR | Sell | 203 | $523.20 | $106K | −0.1% | CEO | |
Jul 15, 2026 | UTHR | Sell | 440 | $524.40 | $231K | −0.1% | CEO | |
Jul 15, 2026 | UTHR | Sell | 280 | $525.24 | $147K | −0.1% | CEO | |
Jul 15, 2026 | UTHR | Sell | 189 | $521.84 | $99K | −0.1% | CEO | |
Jul 15, 2026 | UTHR | Sell | 278 | $530.97 | $148K | −0.7% | CEO | |
Jul 15, 2026 | UTHR | Sell | 800 | $532.06 | $426K | −1.9% | CEO | |
Jul 15, 2026 | UTHR | Sell | 40 | $527.55 | $21K | −0.1% | CEO | |
Jul 15, 2026 | UTHR | Sell | 160 | $533.22 | $85K | −0.4% | CEO | |
Jul 15, 2026 | UTHR | Sell | 80 | $521.82 | $42K | −0.2% | CEO | |
Jul 15, 2026 | UTHR | Sell | 1,044 | $531.03 | $554K | −0.3% | CEO | |
Jul 15, 2026 | UTHR | Sell | 120 | $523.97 | $63K | −0.3% | CEO | |
Jul 15, 2026 | UTHR | Sell | 48 | $520.92 | $25K | −0.0% | CEO | |
Jul 15, 2026 | UTHR | Sell | 577 | $530.12 | $306K | −0.2% | CEO | |
Jul 15, 2026 | UTHR | Sell | 825 | $533.08 | $440K | −0.3% | CEO | |
Jul 15, 2026 | UTHR | Sell | 641 | $529.03 | $339K | −0.2% | CEO | |
Jul 15, 2026 | UTHR | Sell | 3,295 | $531.97 | $1.8M | −1.0% | CEO | |
Jul 10, 2026 | UTHR | Sell | 600 | $540.37 | $324K | −1.2% | CEO | |
Jul 10, 2026 | UTHR | Sell | 400 | $548.44 | $219K | −1.0% | CEO | |
Jul 10, 2026 | UTHR | Sell | 970 | $541.47 | $525K | −2.0% | CEO | |
Jul 10, 2026 | UTHR | Sell | 1,438 | $546.42 | $786K | −3.3% | CEO | |
Jul 10, 2026 | UTHR | Sell | 1,578 | $547.17 | $863K | −3.7% | CEO | |
Jul 10, 2026 | UTHR | Sell | 1,870 | $542.49 | $1.0M | −3.9% | CEO | |
Jul 10, 2026 | UTHR | Sell | 676 | $543.34 | $367K | −1.5% | CEO | |
Jul 10, 2026 | UTHR | Sell | 364 | $544.54 | $198K | −0.8% | CEO | |
Jul 10, 2026 | UTHR | Sell | 1,524 | $545.54 | $831K | −3.3% | CEO | |
Jul 10, 2026 | UTHR | Sell | 80 | $553.47 | $44K | −0.2% | CEO | |
Jul 7, 2026 | UTHR | Sell | 241 | $554.36 | $134K | −0.5% | CEO | |
Jul 7, 2026 | UTHR | Sell | 596 | $555.50 | $331K | −1.2% | CEO | |
Jul 7, 2026 | UTHR | Sell | 200 | $553.12 | $111K | −0.4% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 968 | $479.8M |
Other insiders at UNITED THERAPEUTICS Corp
9 other tracked filers at UTHR.